A clinical trial to evaluate the medicinal efficacy of Ayurvedic Tablet Bhoumya and Tablet Saathmya in COVID-19 positive Patients.
Phase 3
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/06/025671
- Lead Sponsor
- Dr Giridhara Kaje
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients ready to give informed consent
COVID-19 Test - +ve
Patients who can take oral medicine.
Patients aged >18 years both male and female
Uncomplicated illness and Mild Pneumonia Cases
Exclusion Criteria
Patients not ready to give informed consent
Pregnant women and lactating mother
Peadiatric patients 0-18 years
Severe Pneumonia, Acute Respiratory Distress Syndrome, Sepsis & Septic Shock cases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Time in days for Clinical cure:Stable normal clinical temperature and vitals in 3-5-7-10-14 days. <br/ ><br>2.Time in days till RT-PCR is negative . <br/ ><br>3.Rate of improvement of IL-6 levels at 0-7-14 days as compared to baseline. <br/ ><br>Timepoint: From the baseline till the end of 15 days.
- Secondary Outcome Measures
Name Time Method 1.Length of stay in hospital. <br/ ><br>2.Rate of clinical cure at 5-7-10-14 days. <br/ ><br>3.Rate of RT-PCR negativity at 5-7-10-14 days. <br/ ><br>4.Rate of improvement in chest X-ray at 5-7-10-14 days. <br/ ><br>5.Rate of patients ending up with severe pneumonia. <br/ ><br>Timepoint: From the baseline till the end of 1 month.